Fluxid Schwarz Pharma, Inc. - Treatment for Ulcers and other Gastrointestinal Conditions
Fluxid is new disintegrating tablet dosage form of famotidine indicated for the treatment of ulcers, gastroesophageal reflux disease and pathological hypersecretory conditions.
Fluxid (famotidine) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.